Evaluation of in vitro absorption, distribution, metabolism, and excretion and assessment of drug-drug interaction of rucaparib, an orally potent poly(ADP-ribose) polymerase inhibitor.
Saved in:
| Title: | Evaluation of in vitro absorption, distribution, metabolism, and excretion and assessment of drug-drug interaction of rucaparib, an orally potent poly(ADP-ribose) polymerase inhibitor. |
|---|---|
| Authors: | Liao M; Clovis Oncology, Inc., Boulder, CO, USA., Jaw-Tsai S; Clovis Oncology, Inc., Boulder, CO, USA., Beltman J; Clovis Oncology, Inc., Boulder, CO, USA., Simmons AD; Clovis Oncology, Inc., Boulder, CO, USA., Harding TC; Clovis Oncology, Inc., Boulder, CO, USA., Xiao JJ; Clovis Oncology, Inc., Boulder, CO, USA. |
| Source: | Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2020 Sep; Vol. 50 (9), pp. 1032-1042. Date of Electronic Publication: 2020 Mar 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 1306665 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1366-5928 (Electronic) Linking ISSN: 00498254 NLM ISO Abbreviation: Xenobiotica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
